vs
Immunocore Holdings plc（IMCR）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
RESOURCES CONNECTION, INC.的季度营收约是Immunocore Holdings plc的1.1倍（$117.7M vs $104.5M），Immunocore Holdings plc同比增速更快（24.3% vs -19.2%），RESOURCES CONNECTION, INC.自由现金流更多（$15.6M vs $-35.5M），过去两年Immunocore Holdings plc的营收复合增速更高（21.7% vs -11.8%）
Immunocore是一家处于商业化阶段的全球生物技术企业，总部位于英国牛津郡，依托可溶性T细胞受体技术深耕生物药物的研发领域，其创新技术平台为肿瘤、感染性疾病、自身免疫性疾病等多领域的新药开发提供支撑。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
IMCR vs RGP — 直观对比
营收规模更大
RGP
是对方的1.1倍
$104.5M
营收增速更快
IMCR
高出43.5%
-19.2%
自由现金流更多
RGP
多$51.1M
$-35.5M
两年增速更快
IMCR
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $104.5M | $117.7M |
| 净利润 | — | $-12.7M |
| 毛利率 | 97.4% | 37.1% |
| 营业利润率 | -18.8% | -10.3% |
| 净利率 | — | -10.8% |
| 营收同比 | 24.3% | -19.2% |
| 净利润同比 | — | 81.6% |
| 每股收益（稀释后） | $-0.61 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMCRRGP
| Q4 25 | $104.5M | $117.7M | ||
| Q3 25 | $103.7M | $120.2M | ||
| Q2 25 | $98.0M | $139.3M | ||
| Q1 25 | $93.9M | $129.4M | ||
| Q4 24 | $84.1M | $145.6M | ||
| Q3 24 | $80.2M | $136.9M | ||
| Q2 24 | $75.4M | $148.2M | ||
| Q1 24 | $70.5M | $151.3M |
净利润IMCRRGP
| Q4 25 | — | $-12.7M | ||
| Q3 25 | $-177.0K | $-2.4M | ||
| Q2 25 | $-10.3M | $-73.3M | ||
| Q1 25 | $5.0M | $-44.1M | ||
| Q4 24 | — | $-68.7M | ||
| Q3 24 | $8.7M | $-5.7M | ||
| Q2 24 | $-11.6M | $10.5M | ||
| Q1 24 | $-24.4M | $2.5M |
毛利率IMCRRGP
| Q4 25 | 97.4% | 37.1% | ||
| Q3 25 | 99.5% | 39.5% | ||
| Q2 25 | 98.9% | 40.2% | ||
| Q1 25 | 99.1% | 35.1% | ||
| Q4 24 | 99.6% | 38.5% | ||
| Q3 24 | 99.4% | 36.5% | ||
| Q2 24 | 97.7% | 40.2% | ||
| Q1 24 | 99.7% | 37.0% |
营业利润率IMCRRGP
| Q4 25 | -18.8% | -10.3% | ||
| Q3 25 | -6.9% | -1.7% | ||
| Q2 25 | -15.2% | -47.0% | ||
| Q1 25 | -3.9% | -38.4% | ||
| Q4 24 | -23.1% | -52.7% | ||
| Q3 24 | -10.6% | -3.5% | ||
| Q2 24 | -21.2% | 7.6% | ||
| Q1 24 | -37.6% | 2.8% |
净利率IMCRRGP
| Q4 25 | — | -10.8% | ||
| Q3 25 | -0.2% | -2.0% | ||
| Q2 25 | -10.5% | -52.6% | ||
| Q1 25 | 5.4% | -34.0% | ||
| Q4 24 | — | -47.2% | ||
| Q3 24 | 10.9% | -4.2% | ||
| Q2 24 | -15.4% | 7.1% | ||
| Q1 24 | -34.7% | 1.7% |
每股收益（稀释后）IMCRRGP
| Q4 25 | $-0.61 | $-0.38 | ||
| Q3 25 | $0.00 | $-0.07 | ||
| Q2 25 | $-0.20 | $-2.21 | ||
| Q1 25 | $0.10 | $-1.34 | ||
| Q4 24 | $-0.47 | $-2.08 | ||
| Q3 24 | $0.17 | $-0.17 | ||
| Q2 24 | $-0.23 | $0.31 | ||
| Q1 24 | $-0.49 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $864.2M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $381.0M | $194.6M |
| 总资产 | $1.1B | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMCRRGP
| Q4 25 | $864.2M | $89.8M | ||
| Q3 25 | $892.4M | $77.5M | ||
| Q2 25 | $882.8M | $86.1M | ||
| Q1 25 | $837.0M | $72.5M | ||
| Q4 24 | $820.4M | $78.2M | ||
| Q3 24 | $901.3M | $89.6M | ||
| Q2 24 | $859.6M | $108.9M | ||
| Q1 24 | $832.8M | $113.8M |
总债务IMCRRGP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $438.7M | — | ||
| Q2 24 | $452.5M | — | ||
| Q1 24 | $452.5M | — |
股东权益IMCRRGP
| Q4 25 | $381.0M | $194.6M | ||
| Q3 25 | $396.6M | $206.4M | ||
| Q2 25 | $388.5M | $207.1M | ||
| Q1 25 | $378.5M | $277.8M | ||
| Q4 24 | $360.7M | $325.7M | ||
| Q3 24 | $377.8M | $407.2M | ||
| Q2 24 | $359.1M | $418.8M | ||
| Q1 24 | $359.5M | $414.9M |
总资产IMCRRGP
| Q4 25 | $1.1B | $289.3M | ||
| Q3 25 | $1.1B | $287.2M | ||
| Q2 25 | $1.1B | $304.7M | ||
| Q1 25 | $1.0B | $375.6M | ||
| Q4 24 | $1.0B | $424.9M | ||
| Q3 24 | $1.1B | $512.9M | ||
| Q2 24 | $1.0B | $510.9M | ||
| Q1 24 | $994.0M | $523.2M |
负债/权益比IMCRRGP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.26× | — | ||
| Q1 24 | 1.26× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.7M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $-35.5M | $15.6M |
| 自由现金流率自由现金流/营收 | -34.0% | 13.2% |
| 资本支出强度资本支出/营收 | 2.8% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-15.1M | $24.3M |
8季度趋势，按日历期对齐
经营现金流IMCRRGP
| Q4 25 | $-32.7M | $15.9M | ||
| Q3 25 | $-4.5M | $-7.8M | ||
| Q2 25 | $26.0M | $16.8M | ||
| Q1 25 | $435.0K | $659.0K | ||
| Q4 24 | $-14.0M | $1.8M | ||
| Q3 24 | $21.1M | $-309.0K | ||
| Q2 24 | $23.5M | $3.2M | ||
| Q1 24 | $-4.6M | $20.5M |
自由现金流IMCRRGP
| Q4 25 | $-35.5M | $15.6M | ||
| Q3 25 | $-5.2M | $-8.0M | ||
| Q2 25 | $25.6M | $16.5M | ||
| Q1 25 | $137.0K | $238.0K | ||
| Q4 24 | $-17.5M | $61.0K | ||
| Q3 24 | $20.3M | $-575.0K | ||
| Q2 24 | $23.1M | $3.0M | ||
| Q1 24 | $-5.0M | $20.4M |
自由现金流率IMCRRGP
| Q4 25 | -34.0% | 13.2% | ||
| Q3 25 | -5.0% | -6.6% | ||
| Q2 25 | 26.1% | 11.8% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | -20.9% | 0.0% | ||
| Q3 24 | 25.3% | -0.4% | ||
| Q2 24 | 30.7% | 2.1% | ||
| Q1 24 | -7.1% | 13.5% |
资本支出强度IMCRRGP
| Q4 25 | 2.8% | 0.3% | ||
| Q3 25 | 0.7% | 0.1% | ||
| Q2 25 | 0.4% | 0.2% | ||
| Q1 25 | 0.3% | 0.3% | ||
| Q4 24 | 4.3% | 1.2% | ||
| Q3 24 | 1.0% | 0.2% | ||
| Q2 24 | 0.4% | 0.1% | ||
| Q1 24 | 0.6% | 0.1% |
现金转化率IMCRRGP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.42× | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMCR
暂无分部数据
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
